These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31998654)

  • 1. CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer.
    Yu S; Yi M; Xu L; Qin S; Li A; Wu K
    Front Oncol; 2019; 9():1515. PubMed ID: 31998654
    [No Abstract]   [Full Text] [Related]  

  • 2. DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.
    Liu Q; Li A; Yu S; Qin S; Han N; Pestell RG; Han X; Wu K
    J Hematol Oncol; 2018 Apr; 11(1):53. PubMed ID: 29636079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1.
    Zhang X; Niu M; Li T; Wu Y; Gao J; Yi M; Wu K
    Biomark Res; 2023 Dec; 11(1):106. PubMed ID: 38093319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling.
    Han N; Yuan X; Wu H; Xu H; Chu Q; Guo M; Yu S; Chen Y; Wu K
    Oncotarget; 2015 Mar; 6(8):5877-88. PubMed ID: 25788272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
    Pan GF; Zhou XF; Zhao JP
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
    [No Abstract]   [Full Text] [Related]  

  • 7. Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis.
    Qin G; Lian J; Huang L; Zhao Q; Liu S; Zhang Z; Chen X; Yue D; Li L; Li F; Wang L; Umansky V; Zhang B; Yang S; Zhang Y
    Oncoimmunology; 2018; 7(7):e1442167. PubMed ID: 29900050
    [No Abstract]   [Full Text] [Related]  

  • 8. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
    Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
    Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients.
    Gu L; Yao Y; Chen Z
    Transl Cancer Res; 2021 Feb; 10(2):748-758. PubMed ID: 35116406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of CXCL5 in non-small cell lung cancer.
    Wu K; Yu S; Liu Q; Bai X; Zheng X; Wu K
    Onco Targets Ther; 2017; 10():5561-5573. PubMed ID: 29200871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1.
    Zhang Q; Yuan Y; Cui J; Xiao T; Jiang D
    J Cancer; 2015; 6(2):184-91. PubMed ID: 25653720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of SPARC expression in non-small cell lung cancer: A meta-analysis and bioinformatics analysis.
    Ma GY; Shi S; Zhang YR; Guo ZB; Bai WW; Zhang ZG
    Oncol Lett; 2022 Nov; 24(5):412. PubMed ID: 36245823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DACH1 on Proliferation, Invasion, and Apoptosis in Human Lung Adenocarcinoma Cells.
    Yu J; Jiang P; Zhao K; Chen Z; Zuo T; Chen B
    Curr Mol Med; 2021; 21(9):806-811. PubMed ID: 33463463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of DACH1 methylation patterns in lung cancer contributes to cell proliferation and migration.
    Feng Y; Wang L; Wang M
    Biochem Cell Biol; 2018 Oct; 96(5):602-609. PubMed ID: 29590536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Roles of VEGFA and ANGPT2 in Lung Adenocarcinoma and Squamous Cell Carcinoma.
    Qin S; Yi M; Jiao D; Li A; Wu K
    J Cancer; 2020; 11(1):153-167. PubMed ID: 31892982
    [No Abstract]   [Full Text] [Related]  

  • 16. Forkhead box M1 over-expression and dachshund homolog 1 down-regulation as novel biomarkers for progression of endometrial carcinoma in Egyptian patients.
    Hafez AM; Harb OA; Etman WM; Hamed B; Namour AE; Abdelaziz LA
    Contemp Oncol (Pozn); 2021; 25(2):107-117. PubMed ID: 34667437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methylation status of DACH1 gene in esophageal cancer and its clinical significance].
    Liu Y; Li J; Ding H; Xu C; Kou X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Oct; 38(10):1002-1006. PubMed ID: 34625942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.
    Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
    Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
    Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.